United States Antimony Corporation (UAMY): Investor Concerns, Stock Declines, and Potential Legal Options
United States Antimony Corporation (NYSE American: UAMY; NYSE Texas: UAMY) is a U.S.-based company engaged in the production and sale of antimony and zeolite products. Antimony has been designated by the U.S. government as a critical mineral due to its importance in national security, energy infrastructure, and economic stability. Despite this designation and renewed investor interest in critical minerals, UAMY investors have experienced significant volatility and steep losses.
Recent reports indicate that UAMY stock has declined by approximately 90% from certain prior trading highs, raising questions about dilution, capital-raising practices, and the risks disclosed to investors.
Stock Volatility and Dilution Concerns
UAMY experienced a sharp run-up in its share price during 2024–2025 amid heightened attention on domestic critical minerals and supply-chain security. However, that rally was followed by a dramatic correction. Investors reviewing long-term or peak-to-trough charts may observe losses approaching 90% from prior highs.
One major concern cited by investors is repeated equity offerings and the potential for substantial shareholder dilution. Registered direct offerings and shelf-style agreements can place ongoing downward pressure on a company’s stock price, particularly when issued at discounts to prevailing market prices.
Capital Raises and Placement Agents
United States Antimony has relied heavily on capital markets to fund operations and expansion. Several investment banks and placement agents have played key roles in these offerings, including:
- A.G.P./Alliance Global Partners – Served as the exclusive placement agent for multiple registered direct offerings, including transactions in August and October 2025. A.G.P. is also named, alongside B. Riley Securities, Inc., in an agreement that could allow the company to offer up to $400 million in common stock.
- Titan Partners Group, a division of American Capital Partners – Acted as the sole placement agent for a $25 million registered direct offering in October 2025.
- Roth Capital Partners, LLC – Retained as the exclusive placement agent for a prior offering completed in 2021.
- B. Riley Securities, Inc. – Referenced with A.G.P. in connection with the potential $400 million common stock offering.
For existing shareholders, the scale and frequency of these offerings raise questions about whether dilution risks were adequately disclosed and understood at the time of investment.
Issues Investors May Be Questioning
Investors in UAMY may have concerns related to:
- The extent of dilution caused by repeated registered direct offerings
- Whether offering prices and terms were fair and reasonable to existing shareholders
- The timing of capital raises following stock price spikes
- Potential misrepresentations or omissions regarding liquidity needs, operational capacity, or future financing plans
- The disconnect between the company’s role in a critical minerals strategy and its market performance
While volatility alone does not establish wrongdoing, securities laws require accurate disclosures and fair dealing in connection with public offerings and stock promotion.
Potential Investor Recovery Options: FINRA Arbitration
Investors who purchased UAMY shares through brokerage firms or based on recommendations from financial advisors may have potential claims through FINRA arbitration, depending on the facts.
FINRA arbitration may be appropriate where:
- The investment was unsuitable given an investor’s risk tolerance or objectives
- The risks of dilution or speculative trading were not adequately explained
- The investment was recommended in connection with capital-raising activities that primarily benefited insiders or underwriters
- There were misstatements or omissions by brokers or financial advisors
Unlike class actions, FINRA arbitration is typically faster and designed for individual investors seeking to recover losses caused by broker misconduct.
How The White Law Group Can Help
The White Law Group represents investors nationwide in FINRA arbitration and securities litigation. Our attorneys regularly investigate losses involving:
- Micro-cap and small-cap stocks
- Registered direct offerings and private placements
- Excessive dilution and speculative securities
- Broker misconduct and failure to disclose material risks
If you invested in United States Antimony Corporation (UAMY) and suffered losses, you may have legal options. An experienced securities attorney can review your account statements, offering materials, and communications with your broker to determine whether a claim is warranted.
Frequently Asked Questions (FAQs)
Is United States Antimony Corporation (UAMY) a risky investment?
UAMY is generally considered a high-risk, speculative investment. The company operates in a niche sector tied to critical minerals, but its stock has experienced extreme volatility, sharp price swings, and significant dilution from repeated equity offerings. Such characteristics may make the stock unsuitable for conservative or income-focused investors.
Why are repeated stock offerings a concern for UAMY investors?
Registered direct offerings and agreements to issue large amounts of common stock can dilute existing shareholders, reduce earnings per share, and place downward pressure on stock prices. Investors may be concerned if these risks were not clearly disclosed or explained at the time the investment was recommended.
Can UAMY investors recover losses through FINRA arbitration?
Possibly. Investors who purchased UAMY based on a broker or financial advisor’s recommendation may have recovery options through FINRA arbitration, particularly if the investment was unsuitable, risks were misrepresented or omitted, or the recommendation failed to align with the investor’s objectives and risk tolerance.
Free Consultation
To learn more about your rights, contact The White Law Group for a confidential, no-obligation consultation. Time limits may apply under FINRA rules.
